Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-01-20 @ 2:45 AM
Study NCT ID:
NCT05502692
Status:
COMPLETED
Last Update Posted:
2023-05-24
First Post:
2022-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CHARACTERISE - A Cross-sectional, Observational Study to Characterise the Transition to Dolutegravir-based Regimens in South Africa in Terms of the Emergence of Obesity, Viral Re-suppression and Integration Into Routine Programme Care
Sponsor:
University of Witwatersrand, South Africa
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-19
First Submit QC Date:
None
Study First Post Date:
2022-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-23
Last Update Post Date:
2023-05-24
Last Update Post Date Type:
ACTUAL